Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACOPRAD: NACT + Surgery vs Chemoradiation in Cervical Cancer
NCT02422563Phase 3Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2015
- Primary completion
- Oct 2020
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of paclitaxel, carboplatin, cisplatin, ifosfamide in Cervical Cancer (CC), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
paclitaxelcarboplatincisplatinifosfamide
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02422563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422563.